We protect the public and promote the safe and ethical delivery of quality medical care by registrants in Manitoba.
Coming in 2026: Several codeine-containing products (including Tylenol #3, Tylenol #2, and Cotridin) will be added to the M3P druglist
Transferring or receiving patients to ER and urgent care requires collaboration with all health care professionals
An application for reinstatement hearing will be held on February 26, 2025
CPSM requests feedback from registrants, stakeholders, and the general public regarding a proposed amendment to the Practice Direction
